Crossmark

[Translated article] Anifrolumab for the Treatment of Refractory Cutaneous Lupus Erythematosus: A Spanish Clinical Practice-Based Multicenter Study

Crossref DOI link: https://doi.org/10.1016/j.ad.2025.03.009

Published Print: 2025-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Martín-Torregrosa, D.

Mansilla-Polo, M.

Grau-Echavarría, A.

Zaragoza-Ninet, V.

Jara-Rico, N.

Alcalá-García, R.

Torres-Navarro, I.

Botella-Estrada, R.
License Information

Text and Data Mining valid from 2025-05-01

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-03-08
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] Anifrolumab for the Treatment of Refractory Cutaneous Lupus Erythematosus: A Spanish Clinical Practice-Based Multicenter Study

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2025.03.009

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2024.09.023

Content Type: simple-article

Copyright: © 2025 AEDV. Published by Elsevier España, S.L.U.